{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:14:18Z","timestamp":1762604058546},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejps.2017.06.031","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T16:21:31Z","timestamp":1498234891000},"page":"62-70","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Investigating therapeutic usage of combined Ticagrelor and Aspirin through solid-state and analytical studies"],"prefix":"10.1016","volume":"107","author":[{"given":"Hassane","family":"Sadou Yay\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo B.","family":"Rietveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe-Henri","family":"Secr\u00e9tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Faucheron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Karoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Tilleul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najet","family":"Yagoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.06.031_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jps.2600630110","article-title":"Reaction of haloperidol with 5 (hydroxymethyl)-2-furfuraldehyde, an impurity in anhydrous lactose","volume":"63","author":"Almond","year":"1974","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.06.031_bb0010","series-title":"Aulton's Pharmaceutics: The Design and Manufacture of Medicines","author":"Aulton","year":"2013"},{"key":"10.1016\/j.ejps.2017.06.031_bb0015","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1021\/cr9901079","article-title":"Quantitative structure-activity relationships of mutagenic and carcinogenic aromatic amines","volume":"100","author":"Benigni","year":"2000","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2017.06.031_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2012.04.001","article-title":"Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature","volume":"164","author":"Berger","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejps.2017.06.031_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0040-6031(03)00185-0","article-title":"Mechanism of eutectic formation upon compaction and its effects on tablet properties","volume":"404","author":"Bi","year":"2003","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejps.2017.06.031_bb0030","series-title":"Patent US 20030181469 A1","article-title":"Crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound","author":"Bohlin","year":"2003"},{"issue":"1","key":"10.1016\/j.ejps.2017.06.031_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00003495-199346010-00008","article-title":"Eutectic lidocaine\/prilocaine cream","volume":"46","author":"Buckley","year":"1993","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ejps.2017.06.031_bb0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jps.2600770406","article-title":"Decomposition of aspirin in the solid state in the presence of limited amounts of moisture II: kinetics and salting-in of aspirin in aqueous acetic acid solutions","volume":"77","author":"Carstensen","year":"1988","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2017.06.031_bb0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jps.2600770407","article-title":"Decomposition of aspirin in the solid state in the presence of limited amounts of moisture III: effect of temperature and a possible mechanism","volume":"77","author":"Carstensen","year":"1988","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.06.031_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.solmat.2014.11.050","article-title":"Eutectic mixtures of sugar alcohols for thermal energy storage in the 50\u201390\u00b0C temperature range","volume":"134","author":"Diarce","year":"2015","journal-title":"Sol. Energy Mater. Sol. Cells"},{"key":"10.1016\/j.ejps.2017.06.031_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ejps.2017.06.031_bb0060","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600540810","article-title":"Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature","volume":"54","author":"Goldberg","year":"1965","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.06.031_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0040-6031(96)02892-4","article-title":"Contributions of phase diagrams to the understanding of organized polymer-solvent systems","volume":"284","author":"Guenet","year":"1996","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejps.2017.06.031_bb0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2012.07.047","article-title":"Solid\u2013liquid phase diagrams for the determination of the solid state nature of both polymorphs of (RS)-2-(2-oxo-pyrrolidin-1-yl)-butyramide","volume":"437","author":"Herman","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.06.031_bb0075","first-page":"792","article-title":"Photo enhanced modification of human skin elastin in actinic elastosis by N-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction","volume":"108","author":"Horiuchi","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2017.06.031_bb0080","series-title":"Stability Testing of New Drug Substances and Products Q1A (R2) Current Step 4","author":"ICH","year":"2003"},{"key":"10.1016\/j.ejps.2017.06.031_bb0085","series-title":"Quality Risk Management Q9, Current Step 4","author":"ICH","year":"2005"},{"key":"10.1016\/j.ejps.2017.06.031_bb0090","series-title":"Pharmaceutical Development Q8 (R2) Current Step 4","author":"ICH","year":"2009"},{"key":"10.1016\/j.ejps.2017.06.031_bb0095","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1039\/C4CE00878B","article-title":"Implication of microstructure on the mechanical behaviour of an aspirin-paracetamol eutectic mixture","volume":"16","author":"Jain","year":"2014","journal-title":"CrystEngComm"},{"issue":"4","key":"10.1016\/j.ejps.2017.06.031_bb0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.01.003","article-title":"Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"157","author":"James","year":"2009","journal-title":"Am. Heart J."},{"issue":"7","key":"10.1016\/j.ejps.2017.06.031_bb0105","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1248\/cpb.33.2641","article-title":"Structure redetermination and packing analysis of aspirin crystal","volume":"33","author":"Kim","year":"1985","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejps.2017.06.031_bb0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jps.10324","article-title":"Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure","volume":"92","author":"Law","year":"2003","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2017.06.031_bb0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/kin.550160504","article-title":"High-temperature kinetics of thermal decomposition of acetic acid and its products","volume":"16","author":"Mackie","year":"1984","journal-title":"Int. J. Chem. Kinet."},{"key":"10.1016\/j.ejps.2017.06.031_bb0120","doi-asserted-by":"crossref","unstructured":"Nadia A. Mohamed, Nahed A. Abd El-Ghany, Mona M. Fahmy. Thermogravimetric analysis in the evaluation of the inhibition of degradation of rigid poly(vinyl chloride) using biologically active phthalimido aromatic hydrazide derivatives. Polym. Degrad. Stab., Volume 128, June 2016, Pages 46\u201354.","DOI":"10.1016\/j.polymdegradstab.2016.02.014"},{"key":"10.1016\/j.ejps.2017.06.031_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12247-009-9053-7","article-title":"Aqueous solubility enhancement through engineering of binary solid composites: pharmaceutical applications","volume":"4","author":"Moore","year":"2009","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejps.2017.06.031_bb0130","unstructured":"Myers RL. The 100 Most Important Chemical Compounds: A Reference Guide. Greenwood Press, 88 Post Road West, Westport, CT 06881."},{"issue":"2","key":"10.1016\/j.ejps.2017.06.031_bb0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11814-009-0065-2","article-title":"Decomposition of acetic acid by advanced oxidation processes","volume":"26","author":"Park","year":"2009","journal-title":"Korean J. Chem. Eng."},{"key":"10.1016\/j.ejps.2017.06.031_bb0140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/A:1012136608249","article-title":"Cyclodextrins: their future in drug formulation and delivery","volume":"14","author":"Rajewski","year":"1997","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.ejps.2017.06.031_bb0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/09537104.2012.748185","article-title":"Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers","volume":"24","author":"Renli","year":"2013","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.ejps.2017.06.031_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10973-013-3097-0","article-title":"Practical remarks concerning phase diagrams determination on the basis of differential scanning calorimetry measurements","volume":"113","author":"Rycerz","year":"2013","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejps.2017.06.031_bb0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpba.2014.11.046","article-title":"Identification of the major degradation pathways of ticagrelor","volume":"105","author":"Sadou Yaye","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2017.06.031_bb0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tca.2003.11.023","article-title":"An investigation about the solid state thermal degradation of acetylsalicylic acid: polymer formation","volume":"414","author":"Silva","year":"2004","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejps.2017.06.031_bb0165","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jcrysgro.2008.01.054","article-title":"Computer simulation, thermodynamic and microstructural studies of benzamide-benzoic acid eutectic system","volume":"310","author":"Singh","year":"2008","journal-title":"J. Cryst. Growth"},{"issue":"21","key":"10.1016\/j.ejps.2017.06.031_bb0170","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1016\/j.bmcl.2007.07.057","article-title":"From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis","volume":"17","author":"Springthorpe","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2017.06.031_bb0175","first-page":"320","article-title":"Oxidative degradation of linoleic acid methylester in suspensions of inorganic excipients. Part 1","volume":"42","author":"Tischinger-Wagner","year":"1987","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2017.06.031_bb0180","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1021\/tx980022n","article-title":"Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2","volume":"11","author":"Turesky","year":"1998","journal-title":"Chem. Res. Toxicol."},{"issue":"11","key":"10.1016\/j.ejps.2017.06.031_bb0185","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1016\/j.eurpolymj.2007.07.043","article-title":"Binary solid\u2013liquid phase diagram of the two diastereomer racemates of triglycidyl isocyanurate (TGIC)","volume":"43","author":"Vargha","year":"2007","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejps.2017.06.031_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaap.2014.12.024","article-title":"Study on the molecular structure and thermal stability of purine nucleoside analogs","volume":"111","author":"Wang","year":"2015","journal-title":"J. Anal. Appl. Pyrolysis"},{"issue":"1","key":"10.1016\/j.ejps.2017.06.031_bb0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.aogh.2013.12.008","article-title":"The concept of the polypill in the prevention of cardiovascular disease","volume":"80","author":"Wiley","year":"2014","journal-title":"Ann. Glob. Health"},{"key":"10.1016\/j.ejps.2017.06.031_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.semcancer.2004.06.010","article-title":"Environmental and chemical carcinogenesis","volume":"14","author":"Wogan","year":"2004","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.ejps.2017.06.031_bb0205","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jps.20926","article-title":"Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals","volume":"96","author":"Yoshioka","year":"2007","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717303809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717303809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T21:02:39Z","timestamp":1569531759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717303809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":41,"alternative-id":["S0928098717303809"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.06.031","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating therapeutic usage of combined Ticagrelor and Aspirin through solid-state and analytical studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}